Litcius/Paper detail

Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V–STORM): a phase 2, open-label, randomised controlled trial

Piet Ost, Shankar Siva, Sigmund Brabrand, Piet Dirix, Nick Liefhooghe, François-Xavier Otte, Alfonso Gómez‐Iturriaga, Wouter Everaerts, Mohamed Shelan, Antonio J. Conde-Moreno, Fernando López‐Campos, Alexandros Papachristofilou, Matthias Gückenberger, Marta Scorsetti, A. Zapatero, Ana-Elena Villafranca Iturre, C. Eíto, Felipe Couñago, Paolo Muto, Wim Duthoy, Nicolas Mach, Valérie Fonteyne, Daniel Moon, Kristian Thon, Carole Mercier, Vérane Achard, Karin Stellamans, Els Goetghebeur, Dries Reynders, Thomas Zilli

2025The Lancet Oncology69 citationsDOI

Topics & Concepts

MedicineNODALProstate cancerRadiation therapyOpen labelRandomized controlled trialSalvage therapyOncologyMetastasisCancerInternal medicineChemotherapyProstate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchAdvanced Radiotherapy Techniques